— Know what they know.
Not Investment Advice

Financial News

Sentiment 41.6 5156 articles 2711 bullish 1129 bearish Full Index →
📰

Insulet (PODD) Down 8.2% Since Last Earnings Report: Can It Rebound?

Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Insulet (PODD) Down 8.2% Since Last Earnings Report: Can It Rebound?

Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Community Health Systems (CYH) Down 14.8% Since Last Earnings Report: Can It Rebound?

Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Why Is Charles River (CRL) Down 6.8% Since Last Earnings Report?

Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
📰

Bausch (BHC) Down 15.2% Since Last Earnings Report: Can It Rebound?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alibaba Headcount Falls After Sun Art Exit (UPDATED)

Alibaba Headcount Falls After Sun Art Exit (UPDATED)

Editor's note: This article has been updated for clarity around Alibaba Group's workforce changes. While the company has been shifting...
What's Going On With AIM ImmunoTech Stock Friday?

What's Going On With AIM ImmunoTech Stock Friday?

AIM ImmunoTech Inc. (AMEX:AIM) shares slipped on Friday after more than doubling recently, following a sharp rally driven by final approval from the...
What's Going On With AIM ImmunoTech Stock Friday?

What's Going On With AIM ImmunoTech Stock Friday?

AIM ImmunoTech Inc. (AMEX:AIM) shares slipped on Friday after more than doubling recently, following a sharp rally driven by final approval from the...
📰

uniQure N.V. (QURE) Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP; April 13, 2026, Lead Plaintiff Deadline

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
Here's Why You Should Retain AMN HealthCare Stock in Your Po

Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio

AMN rides MSP momentum, AI investments and surging labor disruption demand, but pricing pressure and volatile healthcare trends cloud its near-term...
Here's Why You Should Retain AMN HealthCare Stock in Your Po

Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio

AMN rides MSP momentum, AI investments and surging labor disruption demand, but pricing pressure and volatile healthcare trends cloud its near-term...
Here's Why You Should Retain AMN HealthCare Stock in Your Po

Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio

AMN rides MSP momentum, AI investments and surging labor disruption demand, but pricing pressure and volatile healthcare trends cloud its near-term...
Here's Why You Should Retain AMN HealthCare Stock in Your Po

Here's Why You Should Retain AMN HealthCare Stock in Your Portfolio

AMN rides MSP momentum, AI investments and surging labor disruption demand, but pricing pressure and volatile healthcare trends cloud its near-term...
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings

Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings

U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Friday. Following the market opening Friday, the Dow traded...
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings

Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings

U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Friday. Following the market opening Friday, the Dow traded...
📰

RARE Shareholder Alert: Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Ultragenyx Pharmaceutical Inc....
📰

QURE Shareholder Alert: April 13, 2026 Lead Plaintiff Deadline in uniQure N.V. Securities Class Action Lawsuit — The Gross Law Firm

NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of uniQure N.V....
What's Going On With GSI Technology Stock Today?

What's Going On With GSI Technology Stock Today?

GSI Technology (NASDAQ:GSIT) shares are down during Friday’s premarket session as the company announced the conclusion of its strategic...
Unusual Machines, NuCana, Navigator Holdings And Other Big S

Unusual Machines, NuCana, Navigator Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session

U.S. stock futures were lower this morning, with the Dow futures falling around 200 points on Friday. Shares of Unusual Machines Inc (NYSE:UMAC) fell...
Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Dat

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

Ocugen faces rising cash burn and dilution risk as it advances late-stage gene therapy programs, with 2026-2027 data and filings set to drive...
Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Dat

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

Ocugen faces rising cash burn and dilution risk as it advances late-stage gene therapy programs, with 2026-2027 data and filings set to drive...
Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Dat

Ocugen Stock Outlook: Balancing Cash Burn and Late-Stage Data

Ocugen faces rising cash burn and dilution risk as it advances late-stage gene therapy programs, with 2026-2027 data and filings set to drive...
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Re

Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?

VRTX stock slips nearly 5% as concerns over new drug uptake and pipeline setbacks weigh, even as its dominant CF franchise continues to drive steady...
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Re

Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?

VRTX stock slips nearly 5% as concerns over new drug uptake and pipeline setbacks weigh, even as its dominant CF franchise continues to drive steady...
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Re

Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag?

VRTX stock slips nearly 5% as concerns over new drug uptake and pipeline setbacks weigh, even as its dominant CF franchise continues to drive steady...
SEC Under Bipartisan Pressure To Curb 'Opaque' Chinese Firms

SEC Under Bipartisan Pressure To Curb 'Opaque' Chinese Firms' Access To US Capital Markets

U.S. lawmakers have urged the Securities and Exchange Commission (SEC) to limit Chinese companies’ access to American capital markets, citing...
Super Micro Stock Hits 52-Week Low - Here's Why

Super Micro Stock Hits 52-Week Low - Here's Why

Super Micro Computer Inc. (NASDAQ:SMCI) is under pressure as it extends a sharp selloff into Friday’s premarket session, building on steep...
XPeng Sounds Alarm On China EV Demand With Disappointing Out

XPeng Sounds Alarm On China EV Demand With Disappointing Outlook

XPeng Inc. (NYSE:XPEV) delivered a milestone quarter, swinging to profit and posting robust growth, but a revenue miss and a sharply weaker outlook...
📰

Prestige Consumer Healthcare Announces Agreement to Acquire Breathe Right®, the Leader in Nasal Strips

TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced...
Confluence Investment Management LLC Trims Stock Position in

Confluence Investment Management LLC Trims Stock Position in Gilead Sciences, Inc. $GILD

Confluence Investment Management LLC trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.5% in the 4th quarter,...
Confluence Investment Management LLC Trims Stock Position in

Confluence Investment Management LLC Trims Stock Position in Gilead Sciences, Inc. $GILD

Confluence Investment Management LLC trimmed its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 4.5% in the 4th quarter,...
« Prev 1 17 18 19 20 21 23 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms